Dolby Laboratories $DLB Stock Sold by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. lowered its holdings in shares of Dolby Laboratories (NYSE:DLB) by 15.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 362,743 shares of the electronics maker’s stock after selling 64,948 shares during the quarter. Robeco Institutional Asset Management B.V. owned approximately 0.39% of Dolby Laboratories worth $21,318,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the business. Willis Investment Counsel raised its stake in shares of Dolby Laboratories by 7.2% during the 3rd quarter. Willis Investment Counsel now owns 42,726 shares of the electronics maker’s stock worth $2,511,000 after buying an additional 2,872 shares during the period. Frank Rimerman Advisors LLC lifted its position in shares of Dolby Laboratories by 2.7% during the 3rd quarter. Frank Rimerman Advisors LLC now owns 8,403 shares of the electronics maker’s stock valued at $494,000 after buying an additional 223 shares in the last quarter. Mitchell & Pahl Private Wealth LLC grew its stake in Dolby Laboratories by 8.3% in the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 18,393 shares of the electronics maker’s stock valued at $1,081,000 after acquiring an additional 1,416 shares during the period. CX Institutional grew its stake in Dolby Laboratories by 2.7% in the 3rd quarter. CX Institutional now owns 13,074 shares of the electronics maker’s stock valued at $768,000 after acquiring an additional 347 shares during the period. Finally, Tidal Investments LLC increased its holdings in Dolby Laboratories by 87.7% in the 2nd quarter. Tidal Investments LLC now owns 7,630 shares of the electronics maker’s stock worth $401,000 after acquiring an additional 3,565 shares in the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, SVP Shriram Revankar sold 3,000 shares of Dolby Laboratories stock in a transaction on Friday, August 14th. The stock was sold at an average price of $62.71, for a total transaction of $188,130.00. Following the transaction, the senior vice president owned 73,274 shares in the company, valued at $4,595,012.54. The trade was a 3.93% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Ryan Nicholson sold 1,183 shares of the business’s stock in a transaction dated Tuesday, August 25th. The shares were sold at an average price of $65.28, for a total transaction of $77,226.24. Following the transaction, the chief accounting officer directly owned 34,453 shares in the company, valued at approximately $2,249,091.84. The trade was a 3.32% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 28,889 shares of company stock worth $1,749,388 over the last ninety days. Corporate insiders own 37.93% of the company’s stock.

Dolby Laboratories Price Performance

Shares of NYSE:DLB opened at $62.94 on Friday. The business’s 50 day moving average price is $60.76 and its 200-day moving average price is $57.64. The firm has a market capitalization of $5.90 billion, a PE ratio of 26.78 and a beta of 0.78. Dolby Laboratories has a 1 year low of $48.26 and a 1 year high of $69.95.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings results on Thursday, July 30th. The electronics maker reported $0.69 EPS for the quarter, topping the consensus estimate of $0.67 by $0.02. Dolby Laboratories had a return on equity of 11.08% and a net margin of 16.70%. The firm had revenue of $305.00 million during the quarter, compared to analysts’ expectations of $311.96 million. During the same period in the previous year, the business earned $0.78 earnings per share. The firm’s revenue for the quarter was down 3.3% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, analysts expect that Dolby Laboratories will post 3.23 earnings per share for the current year.

Dolby Laboratories declared that its Board of Directors has approved a share repurchase program on Thursday, July 30th that permits the company to buy back $350.00 million in shares. This buyback authorization permits the electronics maker to purchase up to 7% of its shares through open market purchases. Share buyback programs are usually a sign that the company’s board of directors believes its stock is undervalued.

Dolby Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, August 19th. Stockholders of record on Tuesday, August 11th were given a $0.36 dividend. The ex-dividend date was Tuesday, August 11th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.3%. Dolby Laboratories’s dividend payout ratio is 61.28%.

Analyst Ratings Changes

A number of equities analysts have weighed in on DLB shares. Zacks Research cut shares of Dolby Laboratories from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 15th. Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 target price on shares of Dolby Laboratories in a research report on Friday, August 28th. Weiss Ratings upgraded shares of Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, September 9th. Finally, Wall Street Zen cut shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $87.50.

About Dolby Laboratories

Dolby Laboratories, Inc develops audio and imaging technologies used to enhance entertainment and communications experiences. The company’s technologies are incorporated into cinema, television, broadcast, streaming, mobile, personal computer, automotive and gaming products and services.

Its principal offerings include Dolby Atmos, an object-based audio technology designed to create immersive sound, and Dolby Vision, a high-dynamic-range imaging technology intended to improve picture quality.